MannKind saw decent growth from its two core products in Q2 and just signed a new non-dilutive financing agreement with ...

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...

Good morning, and welcome to the MannKind Corporation Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded on August 6, 2025, and will be available for ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the second quarter 2025 and provided a business ...

As San Diego County braces for triple-digit temperatures, pharmacists urge residents to protect heat-sensitive medications ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good morning, and welcome to the MannKind Corporation Second ...

MannKind Corporation (MNKD) said on Wednesday that it has entered into up to $500 million strategic financing agreement with ...

For the second quarter, total revenues increased 9% to $9.2 billion in comparison to the second quarter of 2024. Product sales grew 9%, driven by 13% volume g ...

HealthDay News — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...

Interested in exploring the benefits of cloves for arousal? You’ve come to the right place. Cloves: one of the final spices you can likely name off the top of your head before giving up a very boring ...

Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...